Olympus Co. (OTCMKTS:OLYMY) Short Interest Update

Olympus Co. (OTCMKTS:OLYMY) was the target of a significant drop in short interest in June. As of June 30th, there was short interest totaling 13 shares, a drop of 99.9% from the June 15th total of 11,090 shares. Based on an average daily volume of 160,531 shares, the short-interest ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group downgraded Olympus from a “buy” rating to a “neutral” rating in a report on Monday, June 15th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Olympus Price Performance

Olympus stock traded up $0.13 during mid-day trading on Friday, hitting $10.87. The stock had a trading volume of 31,621 shares, compared to its average volume of 108,660. The stock has a 50-day simple moving average of $10.82 and a two-hundred day simple moving average of $10.76. Olympus has a 12 month low of $8.08 and a 12 month high of $13.73.

About Olympus

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.